Learn more →
Back to Expert Scholars
pathology / pathologyHematopathology

Elaine Jaffe

伊莱恩·贾菲

MD

🏢National Cancer Institute, NIH(美国国立癌症研究所)🌐USA

Senior Investigator, Hematopathology Section血液病理学高级研究员

82
h-index
2
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Elaine Jaffe is a preeminent hematopathologist at NCI who has shaped the modern classification of lymphoid neoplasms. She has served as a principal architect of the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues across multiple editions.

Share:

🧪Research Fields 研究领域

Hematopathology血液病理学
Lymphoma Classification淋巴瘤分类
WHO ClassificationWHO分类

🎓Key Contributions 主要贡献

WHO Lymphoma Classification

Led development of multiple editions of the WHO Classification of Haematopoietic and Lymphoid Tumours, establishing the global standard for lymphoma diagnosis.

NK/T-cell Lymphoma

Characterized extranodal NK/T-cell lymphoma and other rare T-cell and NK-cell neoplasms, advancing diagnostic accuracy worldwide.

Lymphoma Pathology Education

Trained generations of hematopathologists and authored landmark textbooks widely used in pathology training programs globally.

Representative Works 代表性著作

[1]

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th edition)

IARC Press (2008)

Defining reference for lymphoma classification adopted by pathologists and oncologists worldwide.

[2]

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Blood (2016)

Updated WHO classification integrating molecular and genetic advances into lymphoma diagnosis.

🏆Awards & Recognition 奖项与荣誉

🏆American Society of Hematology Henry Stratton Medal
🏆USCAP Maude Abbott Lecture Award
🏆NCI Director's Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 伊莱恩·贾菲 的研究动态

Follow Elaine Jaffe's research updates

留下邮箱,当我们发布与 Elaine Jaffe(National Cancer Institute, NIH)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment